Polaryx Therapeutics, Inc. EPS (Basic) increased by 54.5% to $-0.05 in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates improved profitability or a reduction in share count, while a decrease suggests declining earnings or equity dilution.
Basic earnings per share represents the portion of a company's profit allocated to each outstanding share of common stoc...
Investors compare this across large-cap technology peers to assess the efficiency of earnings generation relative to the equity base.
eps_basic| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | -$0.11 | -$0.05 |
| QoQ Change | — | +54.5% |
| YoY Change | — | +54.5% |